Literature DB >> 22127245

Effect of progesterone on human mesenchymal stem cells.

Dobroslav S Kyurkchiev1, Ekaterina Ivanova-Todorova, Stanimir D Kyurkchiev.   

Abstract

Progesterone is considered to be a major reproductive steroid hormone which supports the successful development of pregnancy. One of the basic targets of progesterone are stromal cells in endometrium which are triggered to undergo decidualization in preparation to accept the embryo. However, the endometrial stroma consists of different subpopulations of cells with varying characteristics and functions as one of the subpopulations are the endometrial mesenchymal stem cells (MSCs) which seem to be located both in the basal layer and in the functional layer of the endometrium. In all cases, these cells have the features of typical MSCs such as adherence and differentiation in multiple cell lineages. The endometrial MSCs are stimulated by progesterone to increase the expression and secretion of immunomodulatory proteins such as HLA-G and PIBF.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22127245     DOI: 10.1016/B978-0-12-386015-6.00040-8

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  3 in total

Review 1.  HLA-G as a tolerogenic molecule in transplantation and pregnancy.

Authors:  Vera Rebmann; Fabiola da Silva Nardi; Bettina Wagner; Peter A Horn
Journal:  J Immunol Res       Date:  2014-07-21       Impact factor: 4.818

2.  A serum-free medium formulation efficiently supports isolation and propagation of canine adipose-derived mesenchymal stem/stromal cells.

Authors:  Laxminarayana R Devireddy; Michael Myers; Rudell Screven; Zhuoming Liu; Lynne Boxer
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

3.  High Immune Expression of Progesterone-Induced Blocking Factor in Epithelial Ovarian Cancer.

Authors:  Yusuf Madendag; Erdem Sahin; Ilknur Col Madendag; Mefkure Eraslan Sahin; Gokhan Acmaz; Hatice Karaman
Journal:  Technol Cancer Res Treat       Date:  2018-01-01
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.